Alzheimer's disease social impact: Difference between revisions
| Line 8: | Line 8: | ||
==Society and Culture== | ==Society and Culture== | ||
===Social costs=== | ===Social costs=== | ||
Because the median age of the industrialised world's population is gradually increasing, Alzheimer's is a major public health challenge. Much of the concern about the solvency of governmental social safety nets is founded on estimates of the costs of caring for baby boomers, assuming that they develop Alzheimer's in the same proportions as earlier generations. For this reason, money spent informing the public of available effective prevention methods may yield disproportionate benefits.<ref name="pmid11910061"> | Because the median age of the industrialised world's population is gradually increasing, Alzheimer's is a major public health challenge. Much of the concern about the solvency of governmental social safety nets is founded on estimates of the costs of caring for baby boomers, assuming that they develop Alzheimer's in the same proportions as earlier generations. For this reason, money spent informing the public of available effective prevention methods may yield disproportionate benefits.<ref><ref name="pmid11910061"> | ||
<ref name="pmid11910061">{{cite journal |author=Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S |title=The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances |journal=[[Annual Review of Public Health]] |volume=23 |issue= |pages=213–31 |year=2002 |pmid=11910061 |doi=10.1146/annurev.publhealth.23.100901.140525 |url=http://arjournals.annualreviews.org/doi/full/10.1146/annurev.publhealth.23.100901.140525?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed |accessdate=2012-08-20}}</ref> | <ref name="pmid11910061">{{cite journal |author=Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S |title=The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances |journal=[[Annual Review of Public Health]] |volume=23 |issue= |pages=213–31 |year=2002 |pmid=11910061 |doi=10.1146/annurev.publhealth.23.100901.140525 |url=http://arjournals.annualreviews.org/doi/full/10.1146/annurev.publhealth.23.100901.140525?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed |accessdate=2012-08-20}}</ref> | ||
Revision as of 13:15, 20 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Alzheimer's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Alzheimer's disease social impact On the Web |
|
American Roentgen Ray Society Images of Alzheimer's disease social impact |
|
Risk calculators and risk factors for Alzheimer's disease social impact |
Overview
Currently, the national indirect and direct costs of caring for people with Alzheimer's is estimated to be around $100 billion.
Society and Culture
Social costs
Because the median age of the industrialised world's population is gradually increasing, Alzheimer's is a major public health challenge. Much of the concern about the solvency of governmental social safety nets is founded on estimates of the costs of caring for baby boomers, assuming that they develop Alzheimer's in the same proportions as earlier generations. For this reason, money spent informing the public of available effective prevention methods may yield disproportionate benefits.
A 2004 study revealed just how extensive the costs of caring for people with Alzheimer's may become in the near future. If the trends that are currently being witnessed continue at the same rate, the total Federal Medicare spending to treat patients will increase from $62 billion in 200 to $189 billion in 2015.